Clene Inc. at Canaccord Genuity Growth Conference Transcript
(technical difficulty) I'm Sumant Kulkarni, a senior biotechnology analyst here at Canaccord Genuity. It's my pleasure to have Clene Nanomedicine here at what is a really interesting time for the company. They've had some intriguing data with their product. Their approach is extremely different.
With that, I'll turn it over to CEO, Rob Etherington. We also have CFO, Morgan Brown, in the audience. Rob will give us a few opening remarks first 10 minutes or so and run us through this Clene story, and we'll have an interactive Q&A. (Conference Instructions)
With that, Rob?
Thanks, Sumant. It's pleasure to be here today. Very grateful to be invited to the Canaccord Growth Conference.
So forward-looking statement as you've certainly seen before. The number of forward-looking statements that I will make in the course of this next presentation. And we have no need to correct them necessarily. They are forward looking.
So what we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
